MedTrace Logo

Efficacious Iron for Iron Deficiency Anemia in Adults Aged ≥18 Years

NCT06303531 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 111

Last updated 2024-03-25

No results posted yet for this study

Summary

Iron deficiency anemia (IDA) is a widespread condition affecting many people globally. Despite the many cases of IDA, there are few studies that compare the effectiveness of different types of iron supplements with a greater emphasis on the cost of supplements and their tolerability. This study aims to conduct a comparison between different iron supplements to determine the superiority of the iron supplements Ferrous Ascorbate (EBMfer) and Ferrous Fumarate (Eurofer) over polysaccharide iron (FeraMax). This comparison will be conducted by determining the change in hemoglobin levels for participants in this trial over a 3-month period.

Conditions

Interventions

DIETARY_SUPPLEMENT

Ferrous Fumarate

Ferrous Fumarate - 300 mg

DIETARY_SUPPLEMENT

Polysaccharide Iron

Polysaccharide Iron - 150 mg

DIETARY_SUPPLEMENT

Ferrous Ascorbate

Ferrous Ascorbate - 100 mg

Sponsors & Collaborators

  • Dr. Anil K. Gupta Medicine Professional Corporation

    lead NETWORK

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-24
Primary Completion
2025-02-28
Completion
2025-02-28

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06303531 on ClinicalTrials.gov